Sage launches Alzheimer's analytics platform

Sage Bionetworks (Seattle, Wash.) said it launched the Agora platform, "an interactive, web-based tool that allows researchers to explore curated genomic analyses" of Alzheimer’s disease. The platform includes a list of early candidate target nominations for AD.

The platform pools together five years of research from scientists with the Accelerating Medicines Partnership - Alzheimer’s Disease (AMP-AD) Target Discovery and Preclinical Validation Project, which is led by the NIH...